End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
138 SAR | +3.76% | +6.32% | +20.00% |
Business Summary
Sales per Business
SAR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
86.9
%
| 797 | 87.0 % | 957 | 86.9 % | +19.98% |
Consumer Health Products
13.1
%
| 119 | 13.0 % | 144 | 13.1 % | +20.78% |
Sales per region
SAR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Saudi Arabia
65.5
%
| 587 | 64.1 % | 721 | 65.5 % | +22.73% |
Gulf Cooperation Council
12.7
%
| 109 | 11.9 % | 140 | 12.7 % | +28.73% |
Iraq
9.6
%
| 91 | 9.9 % | 105 | 9.6 % | +15.34% |
North Africa and Other Export Markets
6.9
%
| 66 | 7.1 % | 76 | 6.9 % | +15.89% |
Egypt
5.4
%
| 64 | 7.0 % | 59 | 5.4 % | -7.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tarek Hosni
CEO | Chief Executive Officer | 60 | 21-05-14 |
Anwer Muhiddein
DFI | Director of Finance/CFO | 60 | 13-01-12 |
Mohammed Jamjoom
COO | Chief Operating Officer | 29 | 21-08-31 |
Hussam Salousa
PRN | Corporate Officer/Principal | 48 | 22-09-03 |
Mohammed Batarfi
HRO | Human Resources Officer | 40 | 22-01-31 |
Essam Al Sayed
SAM | Sales & Marketing | 57 | 21-10-13 |
Hisham Ahmed
SAM | Sales & Marketing | 57 | 21-06-30 |
Alaa Gamaleldin
PRN | Corporate Officer/Principal | 55 | 21-07-24 |
Wagih El Bokl
PRN | Corporate Officer/Principal | 56 | 21-07-09 |
Idrees Siddiqu
PRN | Corporate Officer/Principal | 57 | 22-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Faris AlGhannam
BRD | Director/Board Member | - | 22-06-18 |
Chairman | 64 | 22-06-18 | |
Founder | 39 | 22-06-18 | |
Director/Board Member | 96 | 22-06-18 | |
Director/Board Member | 63 | 22-06-18 | |
Director/Board Member | 41 | 22-06-18 | |
Director/Board Member | 79 | 22-06-18 | |
Director/Board Member | 44 | 22-06-18 | |
Director/Board Member | - | 22-06-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,000,000 | 21,000,000 ( 30.00 %) | 0 | 30.00 % |
Company contact information
Jamjoom Pharmaceuticals Factory Co.
Jeddah Industrial City Phase Five
21442, Jeddah
+
http://www.jamjoompharma.comSector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.00% | 2.58B | |
+20.83% | 43.57B | |
+20.70% | 22.7B | |
+16.56% | 14.32B | |
+11.11% | 13.42B | |
+45.91% | 11.83B | |
-8.84% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.51B |
- Stock Market
- Equities
- 4015 Stock
- Company Jamjoom Pharmaceuticals Factory Company